Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne W Hancock

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Frontiers in Immunology|July 7, 2022
Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune ResponsesLanette M Christensen, Wayne W Hancock
Gastroenterology|May 17, 2008
Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cellsEdwin F de Zoeten, Wayne W Hancock
Immunology and Cell Biology|January 28, 2009
Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft toleranceLiqing Wang, Ran Tao, Wayne W Hancock
European Journal of Immunology|September 28, 2007
Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft toleranceLiqing Wang, Rongxiang Han, Wayne W Hancock
Cell Cycle (Georgetown, Tex.)|August 25, 2012
Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell functionUlf H Beier, Liqing Wang, Wayne W Hancock
Biochimica Et Biophysica Acta. Reviews on Cancer|June 8, 2018
MEF2 and the tumorigenic process, hic sunt leonesEros Di Giorgio, Wayne W Hancock, Claudio Brancolini
Cells|August 27, 2025
New Approaches to Old Techniques in Cell Handling for MicroscopyZhanna Bartosh, Veenu Aishwarya, Wayne W Hancock, et al.
Journal of Leukocyte Biology|January 4, 2019
Sirtuin-1 in immunotherapy: A Janus-headed targetSakshum Chadha, Liqing Wang, Wayne W Hancock, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 21, 2016
Proximity Ligation Assay to Quantify Foxp3 Acetylation in Regulatory T CellsJing Jiao, Rongxiang Han, Wayne W Hancock, et al.
Current Opinion in Immunology|September 23, 2003
Chemokines and their receptors as markers of allograft rejection and targets for immunosuppressionWayne W Hancock, Liqing Wang, Qunrui Ye, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|July 7, 2022
Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune ResponsesLanette M Christensen, Wayne W Hancock
Gastroenterology|May 17, 2008
Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cellsEdwin F de Zoeten, Wayne W Hancock
Immunology and Cell Biology|January 28, 2009
Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft toleranceLiqing Wang, Ran Tao, Wayne W Hancock
European Journal of Immunology|September 28, 2007
Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft toleranceLiqing Wang, Rongxiang Han, Wayne W Hancock
Cell Cycle (Georgetown, Tex.)|August 25, 2012
Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell functionUlf H Beier, Liqing Wang, Wayne W Hancock
Biochimica Et Biophysica Acta. Reviews on Cancer|June 8, 2018
MEF2 and the tumorigenic process, hic sunt leonesEros Di Giorgio, Wayne W Hancock, Claudio Brancolini
Cells|August 27, 2025
New Approaches to Old Techniques in Cell Handling for MicroscopyZhanna Bartosh, Veenu Aishwarya, Wayne W Hancock, et al.
Journal of Leukocyte Biology|January 4, 2019
Sirtuin-1 in immunotherapy: A Janus-headed targetSakshum Chadha, Liqing Wang, Wayne W Hancock, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 21, 2016
Proximity Ligation Assay to Quantify Foxp3 Acetylation in Regulatory T CellsJing Jiao, Rongxiang Han, Wayne W Hancock, et al.
Current Opinion in Immunology|September 23, 2003
Chemokines and their receptors as markers of allograft rejection and targets for immunosuppressionWayne W Hancock, Liqing Wang, Qunrui Ye, et al.
Pageof 18